Tafinlar Oral Capsule 50Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Tafinlar: Oral capsule (50mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

DABRAFENIB (da braf e nib) is a medicine that targets proteins in cancer cells and stops the cancer cells from growing. It is used to treat melanoma, non-small cell lung cancer, and thyroid cancer.

In-Depth Information
Select a Medication

Tafinlar 50mg Capsule

NDC: 000780682
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Malignant Melanoma, Non-small Cell Lung Cancer (NSCLC), Thyroid Cancer

Storage Information
Store at 77 degrees F; excursions permitted to 59-86 degrees F
Tafinlar 50mg Capsule

Reported Side Effects for Tafinlar 50mg Capsule

Blistery Rash Incidence:
<10.0%*
Severity: MODERATE
Onset: EARLY
Intestinal Bleeding Incidence:
<6.0%*
Severity: SEVERE
Onset: DELAYED
Low Albumin In Blood Incidence:
<1.1%*
Severity: SEVERE
Onset: DELAYED
Infection Incidence:
<12.0%*
Severity: MILD
Onset: DELAYED
Bleeding In The Brain Incidence:
<1.4%*
Severity: SEVERE
Onset: DELAYED
Low White Blood Cell Counts Incidence:
<8.0%*
Severity: SEVERE
Onset: DELAYED
Inflamed Pancreas Incidence:
<10.0%*
Severity: SEVERE
Onset: DELAYED
Fluid Retention Incidence:
<0.7%*
Severity: SEVERE
Onset: DELAYED
Bleeding In The Abdomen Incidence:
<2.2%*
Severity: SEVERE
Onset: DELAYED
Breakdown Of Muscle Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Vomiting Incidence:
<3.2%*
Severity: SEVERE
Onset: EARLY
Weakness Incidence:
<5.0%*
Severity: SEVERE
Onset: DELAYED
Back Pain Incidence:
<3.0%*
Severity: SEVERE
Onset: DELAYED
Blurred Vision Incidence:
<6.0%*
Severity: MODERATE
Onset: EARLY
Anemia Incidence:
<10.0%*
Severity: SEVERE
Onset: DELAYED
Lightheadedness Incidence:
<0.2%*
Severity: SEVERE
Onset: EARLY
Elevated Hepatic Enzymes Incidence:
<6.0%*
Severity: SEVERE
Onset: DELAYED
Hyperkeratosis Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Kidney Inflammation Incidence:
<10.0%*
Severity: SEVERE
Onset: DELAYED
Feeling Sick Incidence:
<5.0%*
Severity: SEVERE
Onset: EARLY
Hand And Foot Syndrome Incidence:
<2.0%*
Severity: SEVERE
Onset: DELAYED
Skin Rash Incidence:
<3.2%*
Severity: SEVERE
Onset: EARLY
Upset Stomach Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
New Primary Malignancy Incidence:
<11.0%*
Severity: SEVERE
Onset: DELAYED
Dry Skin Incidence:
<1.1%*
Severity: SEVERE
Onset: DELAYED
Hair Loss Incidence:
<22.0%*
Severity: MILD
Onset: DELAYED
Decreased Appetite Incidence:
<29.0%*
Severity: MILD
Onset: DELAYED
Joint Pain Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Constipation Incidence:
<2.0%*
Severity: SEVERE
Onset: DELAYED
Cough Incidence:
<22.0%*
Severity: MILD
Onset: DELAYED
Loose Stools Incidence:
<2.2%*
Severity: SEVERE
Onset: EARLY
Shortness Of Breath Incidence:
<5.0%*
Severity: SEVERE
Onset: EARLY
Swelling Incidence:
<28.0%*
Severity: MODERATE
Onset: DELAYED
Tired Incidence:
<5.0%*
Severity: SEVERE
Onset: EARLY
Headache Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Low Blood Sodium Levels Incidence:
<17.0%*
Severity: SEVERE
Onset: DELAYED
Bleeding Incidence:
<3.2%*
Severity: SEVERE
Onset: EARLY
Low Platelet Count Incidence:
<0.7%*
Severity: SEVERE
Onset: DELAYED
Lung Inflammation Incidence:
<2.4%*
Severity: MODERATE
Onset: DELAYED
Sore Throat Incidence:
<12.0%*
Severity: MILD
Onset: DELAYED
Muscle Pain Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Low Phosphate Level Incidence:
<7.0%*
Severity: SEVERE
Onset: DELAYED
Chills Incidence:
0.5-1.1%*
Severity: SEVERE
Onset: RAPID
Kidney Failure Incidence:
0.5%*
Severity: SEVERE
Onset: DELAYED
Fainting Incidence:
0.7%*
Severity: MILD
Onset: EARLY
Eye Inflammation Incidence:
1.0-2.0%*
Severity: SEVERE
Onset: DELAYED
Dehydration Incidence:
1.8%*
Severity: MODERATE
Onset: DELAYED
Heart Muscle Disease Incidence:
2.9-9.0%*
Severity: SEVERE
Onset: DELAYED
Fever Incidence:
3.0-5.0%*
Severity: SEVERE
Onset: EARLY
Increased Blood Sugar Incidence:
3.0-9.0%*
Severity: SEVERE
Onset: DELAYED
Low Lymphocytes Incidence:
5.0-14.0%*
Severity: SEVERE
Onset: DELAYED
Low White Blood Cells Incidence:
6.0-8.0%*
Severity: SEVERE
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for Tafinlar 50mg Capsule

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Major Lifestyle Interaction
Grapefruit juice and Tafinlar 50mg Capsule(Dabrafenib)
Grapefruit juice and Dabrafenib(Dabrafenib)
If you drink grapefruit juice, talk to your health care professional. Do not take dabrafenib with grapefruit juice because taking these together may result in increased dabrafenib levels in your body and an increased risk of dabrafenib side effects.
Pregnancy & Lactation Information
First Trimester

Class 3 - Risk Documented in Animals

Second Trimester

Class 3 - Risk Documented in Animals

Third Trimester

Class 3 - Risk Documented in Animals

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Tafinlar

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5